Denmark vs Fiji: The number of people with susceptibility test result for rifampicin
Denmark
96.58
in 2021
Fiji
96.21
in 2021
Denmark rank
43rd
Fiji rank
45th
The number of people with susceptibility test result for rifampicin over time
- Denmark
- Fiji
How they compare
Denmark currently reports 96.58 against 96.21 in Fiji, a difference of 0.37.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Fiji ahead.
Denmark ranks 43rd and Fiji ranks 45th of 146 countries.
Fiji has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Denmark | Fiji | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 97.19 | 103.21 | 6.02 | Fiji |
| 2020s | 96.41 | 98.11 | 1.7 | Fiji |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Denmark or Fiji?
- Denmark, at 96.58 against 96.21 in Fiji as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Denmark and Fiji?
- 0.37, with Denmark ahead.
- How many years of comparable data are there for Denmark and Fiji?
- 5 years are reported by both, from 2017 to 2021.
- How do Denmark and Fiji rank globally for the number of people with susceptibility test result for rifampicin?
- Denmark ranks 43rd and Fiji ranks 45th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.